# NAPROSYN
> **NDA018965** · New Drug Application · Sponsor: ATNAHS PHARMA US · Approved 1987-03-23
## Drug
- **FDA Application Number:** NDA018965
- **Application type:** New Drug Application
- **Brand name:** NAPROSYN
- **Generic name:** NAPROXEN
- **Active ingredients:** NAPROXEN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ATNAHS PHARMA US
- **Manufacturer:** Acella Pharmaceuticals, LLC
- **First approval:** 1987-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018965)
---
*MORVS · CC0 1.0*